China Biologic gets $3.9 billion offer from former CEO-led consortium: Reuters

China Biologic Products Holdings Inc (CBPO.O) on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the company’s former chief executive David Gao, Reuters reported.

20 August 2018•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail